Implantable cardioverter-defibrillator in hypertrophic cardiomyopathy.

Glob Cardiol Sci Pract · 2018 · PMC6209444 · PMID 30393643

Europe PMC DOI

hedged sentence

0.1600

closest p · 3.2× alpha

0.1600

boldest claim

The sentences

did not reach statistical significanceP = 0.16not close (p > 0.1)

While the prevalence of high DFT (>15 J) tended to be greater in the HCM group (17% vs 12%), this did not reach statistical significance ( P = 0.16).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.